|
Organization |
| Founded in 2002, Concurrent Analytical Inc.
is a privately held Delaware C-Corporation. Concurrent
Analytical Inc. operates two commercial divisions, Nanopartz (www.nanopartz.com)
and Directed Bioflux (www.dbflux.com). |
|
X rays are a hoax.
-- New York Times headline, 1911
I think that there is a world market for
about five computers.
-- Thomas Watson, Chairman of IBM, 1943
640K [of memory] ought to be enough for anybody.
-- Bill Gates, CEO of Microsoft, 1981
The cloning of mammals…is biologically impossible.
-- Science, 1984
|
 |
About Us |
 |
Concurrent Analytical is developing the Ramanprobes
technology. This technology has been funded by the National Defense Center of Excellence for Research
in Ocean Sciences (CEROS) Defense Advanced Research Projects
Agency (DARPA), National Institute of Health (NIH) as well as private investment and commercial
sales. Through our research sponsors, we have raised over
$3M in grants and supported over $1.5M in sponsored University research.

(L-R) Bob Lipert, Marc Porter, and Chris Schoen
 |
Who We Are |
 |
Officers and Board Members
Shelley J. Coldiron, Ph.D., President and CEO,
shelley.coldiron@concana.com, was most recently Co-Founder,
Director, President & CEO of CombiSep, Inc. - With over 25 years
experience, Dr. Coldiron has a diverse background in instrumentation,
analytical chemistry, bioengineering, environmental chemistry and
entrepreneurism - serving in private, public and government sectors. Dr.
Coldiron was responsible for all operating aspects of CombiSep. CombiSep
has developed and is manufacturing analytical instrumentation for high
throughput screening and separations that will support the paradigm
shift that is occurring in drug discovery, combinatorial chemistry, high
throughput process chemistry and biochemistry, clinical chemistry and
proteomics. Dr. Coldiron raised over $6.5M in funds for CombiSep
from government grants, government loans, commercial loans, private
loans, and two rounds of private equity. Prior to founding CombiSep, she
was a Co-Founder, Director and President of Advanced Analytical
Technologies, responsible for all operating aspects of that firm until
August 1999 and successfully raised $3M in private equity to develop
food safety testing technologies. In total, she has raised over $9.5M in
funding for both companies that she co-founded.
Christian L. Schoen, Ph.D. Founder, VP Marketing and Product Development
and CTO, cschoen@concana.com.
Dr. Schoen received his BSEE from UCLA, an MSEE from USC, and his
PhD from the University of Hawaii in 1992. He has over 20 years of laser
optical experience, more specifically in Raman spectroscopy. He has
worked for Hughes Aircraft, TRW, as a contractor to Lawrence Livermore
National Labs (LLNL), and as a faculty member of the University of
Hawaii. Prior to founding Concurrent Analytical Inc., he was President
and founder of Detection Limit Technology Inc., a company that
revolutionized portable Raman instrumentation. His inventions have
generated millions of dollars in sales, and he has been PI on more than
$5M in research grants. He is the inventor on two patents, the author of
eleven journal publications and ten conference proceedings, and has been
an invited speaker at PittCon.

Advisory Board Members
Marc D. Porter Ph.D., Advisory
Board Member. Dr. Porter is a Professor at the
University of Utah. Previously he was Director of
the Microanalytical Instrumentation Center at Iowa State University.
Dr. Porter received BS and MS degrees
from Wright State University and a PhD from
The Ohio State University in 1984. After a post-doctoral appointment
with D. Allara at Bell Laboratories, he joined the faculty at the
chemistry department of Iowa State University, and recently held the
rank of Professor and Director of the University's Microanalytical
Instrumentation Center. He has received a Special Creativity Grant
Extension Award from NSF in 1993 and was the recipient of the Wright
Brothers Award from the Society of Aeronautical Engineers in 1993. He
is currently serving on the Analytical Chemistry Advisory Board. He is
affiliated with the American Chemical Society, The Electrochemical
Society, and the Society for Applied Spectroscopy. He has over 130
publications, and has given over 225 presentations at national and
international meetings. He has also given over 100 invited talks at
various universities and industries. He holds 8 patents, with several
more pending. His research interests focus largely on the role of
interfaces in analytical chemistry, including electrochemically
modulated liquid chromatography, electrocatalysis, organic monolayer
films and the chemical modification of surfaces, scanning probe
microscopies, infrared and Raman spectroscopies, and fiber optic and
acoustic wave sensors.
Robert
J. Lipert Ph.D., Advisory Board Member. Dr. Lipert is
currently an Associate Scientist at Iowa State University at the
Microanalytical Instrumentation Center. He received a BS in chemistry
from the University of Wisconsin-Eau Claire in 1974 and a PhD in
physical chemistry from Yale University in 1990. He then joined the
Ames Laboratory, at Iowa State University in the nuclear safeguards and
security program developing high resolution laser spectroscopy
techniques for isotopic characterizations. In 1994 he joined the
Microanalytical Instrumentation Center, conducting research in the areas
of piezoelectric mass sensors, infrared specular reflectance
spectroscopy, Raman and Surface Enhance Raman Spectroscopy of thin
films, and flow cytometry instrument development. He is affiliated with
the American Chemical Society, the American Physical Society, and the
Society for Applied Spectroscopy. He has 24 publications and 3 pending
patents.
|
History
Concurrent Analytical Inc.
was founded in 2002 based upon a successful
collaboration between Iowa State
University's Dr. Marc Porter and his ERL
technology, and Dr. Christian Schoen's
compact, portable, high sensitivity Raman
instrument inventions. Among other
achievements, the combination of the
Nanoraman instrument and Dr. Marc
Porter's ERL technology saw instant
success in sensitivity and specificity.
Since its founding,
Concurrent Analytical has made continuous
enhancements to the original technology.
Currently, the Ramanprobes system is
capable of attomolar detection of viruses in
blood in less than ten seconds.
The company is now a
complete multi-level manufacturing
operation with leading edge research and
development teams, and veteran customer
service and support.

|
|